National Cancer Institute comorbidity index

There are 4 papers on National Cancer Institute comorbidity index in aging research: 4 observational studies in people.

Biomarker

4 papers study it4 more mention it1 finding

See all 8 papers on National Cancer Institute comorbidity index

“The NCI (continuous score) showed a stronger association with overall mortality (hazard ratio (HR) 2.47, 95%CI:2.29-2.67) than the other indices”
Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancerCancer epidemiology2023doi:10.1016/j.canep.2023.102482
  • Humans4

Associations

1

Overall mortality

upin humans1HR 2.47

1 study
  1. National Cancer Institute comorbidity index predicts overall mortality in humans (non-metastatic prostate cancer) (HR 2.47, 95% CI 2.29-2.67).

    “The NCI (continuous score) showed a stronger association with overall mortality (hazard ratio (HR) 2.47, 95%CI:2.29-2.67) than the other indices”

    Humansnon-metastatic prostate cancermalesn = 11,470

    Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer

    Cancer epidemiology

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 02 papers in 12 months